Crinetics Pharmaceuticals Inc. (CRNX) NASDAQ

$18 0.26 (1.47%)

Market Cap: $963.10M

As of 06/29/22 04:00 PM EDT. Market closed.

(CRNX)

Crinetics Pharmaceuticals Inc. (CRNX) NASDAQ

$18 0.26 (1.47%)

Market Cap: $963.10M

As of 06/29/22 04:00 PM EDT. Market closed.

Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate, paltusotine (formerly CRN00808), is an oral selective nonpeptide somatostatin receptor type 2 biased agonist undergoing two Phase 2 clinical trials for ... read more

Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate, paltusotine (formerly CRN00808), is an oral selective nonpeptide somatostatin receptor type 2 biased agonist undergoing two Phase 2 clinical trials for the treatment of acromegaly, an orphan disease affecting more than 25,000 people in the United States. Crinetics plans to advance paltusotine into a Phase 3 trial in acromegaly and a Phase 2 trial for the treatment of carcinoid syndrome associated with NETs in 2021. The company is also developing CRN04777, an oral nonpeptide somatostatin receptor type 5 (SST5) agonist for hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease, congenital adrenal hyperplasia and other diseases of excess ACTH. All of the company's drug candidates are new chemical entities resulting from in-house drug discovery efforts and are wholly owned by the company read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
R. Scott Struthers
Full Time Employees
93
CEO Compensation (Base)
$409,913
CEO Compensation (Total)
$3.04M
URL
Address
10222 Barnes Canyon Rd Bldg 2, California, San Diego, 92121-2711.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
R. Scott Struthers
Full Time Employees
93
CEO Compensation (Base)
$409,913
CEO Compensation (Total)
$3.04M
Address
10222 Barnes Canyon Rd Bldg 2, California, San Diego, 92121-2711.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$17.85
Previous Close
$17.74
Days Range
$17.29 - $18.11
52 week range
$15.91 - $28.95
Volume
130,820
Avg. Volume (30 days)
367,252
Market Cap
$963.10M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
53,505,809
Open
$17.85
Previous Close
$17.74
Days Range
$17.29 - $18.11
52 week range
$15.91 - $28.95
Volume
130,820
Avg. Volume (30 days)
367,252
Market Cap
$963.10M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
53,505,809

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CRINETICS PHARMACEUTICALS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Betz Stephen F. Chief Scientific Officer May 02, 2022 Sale $20.10 3,247 65,252 107,598 May 04, 2022, 05:01 PM
Betz Stephen F. Chief Scientific Officer Apr 18, 2022 Sale $25.81 5,664 146,188 110,845 Apr 21, 2022, 05:00 PM
PERCEPTIVE ADVISORS LLC 10% Owner Apr 18, 2022 Buy $22.22 157,515 3,499,983 5,321,032 Apr 18, 2022, 05:39 PM
Struthers Richard Scott President & CEO Apr 13, 2022 Sale $26.83 138,643 3,719,625 844,774 Apr 15, 2022, 06:00 PM
Struthers Richard Scott President & CEO Apr 05, 2022 Sale $25.34 21,357 541,225 869,448 Apr 07, 2022, 05:58 PM
Betz Stephen F. Chief Scientific Officer Apr 04, 2022 Sale $23.97 9,000 215,761 116,509 Apr 06, 2022, 07:08 PM
Betz Stephen F. Chief Scientific Officer Apr 01, 2022 Sale $21.80 4,164 90,775 125,509 Apr 01, 2022, 05:39 PM
Betz Stephen F. Chief Scientific Officer Mar 31, 2022 Sale $21.06 4,164 87,700 129,673 Apr 01, 2022, 05:39 PM
Betz Stephen F. Chief Scientific Officer Mar 15, 2022 Sale $18.94 3,123 59,150 133,837 Mar 17, 2022, 04:33 PM
Madan Ajay Chief Development Officer Mar 01, 2022 Sale $19.88 9,000 178,920 176,995 Mar 02, 2022, 09:00 PM
Betz Stephen F. Chief Scientific Officer Mar 01, 2022 Sale $19.73 3,123 61,617 136,960 Mar 02, 2022, 09:00 PM
Betz Stephen F. Chief Scientific Officer Feb 15, 2022 Sale $18.64 3,123 58,213 123,583 Feb 17, 2022, 04:34 PM
Madan Ajay Chief Development Officer Feb 07, 2022 Sale $17.83 13,411 239,085 172,045 Feb 09, 2022, 05:00 PM
Betz Stephen F. Chief Scientific Officer Feb 01, 2022 Sale $18.79 3,123 58,681 126,706 Feb 03, 2022, 04:30 PM
Krasner Alan Seth Chief Medical Officer Jan 19, 2022 Option Exercise $12.01 6,700 80,467 15,011 Jan 21, 2022, 04:54 PM
Krasner Alan Seth Chief Medical Officer Jan 19, 2022 Sale $21.21 6,700 142,080 8,311 Jan 21, 2022, 04:54 PM
Betz Stephen F. Chief Scientific Officer Jan 18, 2022 Sale $23.29 4,168 97,073 128,875 Jan 20, 2022, 04:47 PM
Betz Stephen F. Chief Scientific Officer Jan 03, 2022 Sale $28.02 7,168 200,847 133,043 Jan 06, 2022, 04:37 PM
Betz Stephen F. Chief Scientific Officer Dec 28, 2021 Sale $27.95 3,000 83,852 140,211 Dec 30, 2021, 07:19 PM
Betz Stephen F. Chief Scientific Officer Dec 15, 2021 Sale $24.14 5,668 136,826 143,211 Dec 17, 2021, 04:28 PM
Betz Stephen F. Chief Scientific Officer Dec 01, 2021 Sale $27.38 5,668 155,190 148,879 Dec 03, 2021, 04:36 PM
Betz Stephen F. Chief Scientific Officer Nov 15, 2021 Sale $26.75 5,668 151,619 156,047 Nov 17, 2021, 05:01 PM
Betz Stephen F. Chief Scientific Officer Nov 16, 2021 Sale $27.97 1,500 41,955 154,547 Nov 17, 2021, 05:01 PM
Betz Stephen F. Chief Scientific Officer Nov 08, 2021 Sale $28.42 3,900 110,846 161,715 Nov 09, 2021, 05:44 PM
Betz Stephen F. Chief Scientific Officer Nov 05, 2021 Sale $27.95 12,600 352,195 165,615 Nov 09, 2021, 05:44 PM
Betz Stephen F. Chief Scientific Officer Nov 01, 2021 Sale $24.79 5,668 140,510 178,215 Nov 03, 2021, 04:57 PM
Fust Matthew K Director Nov 01, 2021 Option Exercise $1.91 8,954 17,102 21,490 Nov 03, 2021, 04:55 PM
Fust Matthew K Director Nov 01, 2021 Sale $25.50 8,954 228,327 12,536 Nov 03, 2021, 04:55 PM
Madan Ajay Chief Development Officer Oct 28, 2021 Option Exercise $0.73 106,383 77,660 184,671 Nov 01, 2021, 07:11 PM
Betz Stephen F. Chief Scientific Officer Oct 27, 2021 Sale $24.00 3,000 71,991 183,883 Oct 28, 2021, 05:00 PM
Betz Stephen F. Chief Scientific Officer Oct 21, 2021 Sale $21.10 1,042 21,984 186,883 Oct 25, 2021, 04:28 PM
PERCEPTIVE ADVISORS LLC 10% Owner Oct 25, 2021 Buy $19.80 1,200,000 23,759,999 5,163,517 Oct 25, 2021, 02:47 PM
Fust Matthew K Director Sep 08, 2021 Option Exercise $1.91 6,046 11,548 18,582 Sep 09, 2021, 05:00 PM
Fust Matthew K Director Sep 08, 2021 Sale $25.50 6,046 154,173 12,536 Sep 09, 2021, 05:00 PM
Struthers Richard Scott President & CEO Sep 07, 2021 Sale $25.00 10,000 250,000 90,000 Sep 09, 2021, 05:00 PM
Struthers Richard Scott President & CEO Sep 07, 2021 Sale $25.00 10,000 250,000 90,000 Sep 09, 2021, 05:00 PM
Struthers Richard Scott President & CEO Sep 07, 2021 Sale $25.00 10,000 250,000 90,000 Sep 09, 2021, 05:00 PM
Fust Matthew K Director Jul 26, 2021 Option Exercise $1.91 5,000 9,550 17,536 Jul 27, 2021, 08:00 PM
Fust Matthew K Director Jul 26, 2021 Sale $19.59 5,000 97,950 12,536 Jul 27, 2021, 08:00 PM
Fust Matthew K Director Jul 19, 2021 Option Exercise $1.91 5,000 9,550 17,536 Jul 20, 2021, 05:00 PM
Fust Matthew K Director Jul 19, 2021 Sale $19.50 5,000 97,500 12,536 Jul 20, 2021, 05:00 PM
Fust Matthew K Director Jul 12, 2021 Option Exercise $1.91 5,000 9,550 17,536 Jul 13, 2021, 05:00 PM
Fust Matthew K Director Jul 12, 2021 Sale $20.71 5,000 103,550 12,536 Jul 13, 2021, 05:00 PM
PERCEPTIVE ADVISORS LLC 10% Owner Apr 08, 2021 Buy $16.44 304,136 4,999,996 3,963,517 Apr 09, 2021, 09:00 AM
Struthers Richard Scott President & CEO Dec 03, 2020 Buy $13.10 4,000 52,400 4,000 Dec 04, 2020, 04:59 PM
Struthers Richard Scott President & CEO Dec 02, 2020 Buy $12.60 1,000 12,600 1,000 Dec 04, 2020, 04:59 PM
Struthers Richard Scott President & CEO Jul 16, 2020 Sale $14.46 17,500 253,108 890,805 Jul 17, 2020, 05:05 PM
Struthers Richard Scott President & CEO Jul 15, 2020 Sale $15.30 17,500 267,722 908,305 Jul 17, 2020, 05:05 PM
WIERENGA WENDALL Director Apr 28, 2020 Option Exercise $0.73 25,329 18,490 99,846 Apr 29, 2020, 05:01 PM
PERCEPTIVE ADVISORS LLC 10% Owner Apr 17, 2020 Buy $14.00 1,071,428 14,999,992 3,659,381 Apr 20, 2020, 08:30 AM
Vivo Capital VIII, LLC 10% Owner Apr 17, 2020 Sale $15.40 84,598 1,302,809 2,162,587 Apr 17, 2020, 06:38 PM
Vivo Capital VIII, LLC 10% Owner Apr 16, 2020 Sale $15.20 30,190 458,888 2,236,920 Apr 17, 2020, 06:38 PM
Vivo Capital VIII, LLC 10% Owner Apr 15, 2020 Sale $15.50 215,810 3,345,055 2,263,447 Apr 17, 2020, 06:38 PM
Vivo Capital VIII, LLC 10% Owner Apr 03, 2020 Sale $13.80 300,000 4,140,000 2,458,445 Apr 07, 2020, 07:27 PM
Vivo Capital VIII, LLC 10% Owner Apr 07, 2020 Sale $14.20 6,115 86,833 2,453,072 Apr 07, 2020, 07:27 PM
Vivo Capital VIII, LLC 10% Owner Mar 09, 2020 Sale $19.50 528 10,296 2,722,045 Mar 11, 2020, 05:12 PM
Vivo Capital VIII, LLC 10% Owner Feb 10, 2020 Sale $21.40 7,555 161,677 2,722,392 Feb 11, 2020, 08:00 PM
Vivo Capital VIII, LLC 10% Owner Feb 07, 2020 Sale $22.00 5,905 129,910 2,723,843 Feb 11, 2020, 08:00 PM
Vivo Capital VIII, LLC 10% Owner Feb 04, 2020 Sale $22.80 13,460 306,888 2,724,977 Feb 06, 2020, 07:22 PM
Vivo Capital VIII, LLC 10% Owner Jan 30, 2020 Sale $22.10 7,600 167,960 2,728,598 Jan 31, 2020, 08:00 PM
Vivo Capital VIII, LLC 10% Owner Jan 29, 2020 Sale $22.20 13,920 309,024 2,730,057 Jan 31, 2020, 08:00 PM
Vivo Capital VIII, LLC 10% Owner Jan 31, 2020 Sale $21.70 5,400 117,180 2,727,561 Jan 31, 2020, 08:00 PM
Fust Matthew K Director Dec 16, 2019 Option Exercise $1.91 3,500 6,685 16,036 Dec 18, 2019, 06:32 PM
Fust Matthew K Director Dec 16, 2019 Sale $22.50 3,500 78,750 12,536 Dec 18, 2019, 06:32 PM
Struthers Richard Scott President & CEO Aug 05, 2019 Option Exercise $1.91 10,000 19,100 1,225,805 Aug 07, 2019, 07:31 PM
5AM Ventures IV, L.P. Former 10% holder Jun 21, 2019 Sale $22.20 250,000 5,550,000 2,267,797 Jun 25, 2019, 07:03 PM
Vivo Capital VIII, LLC 10% Owner Mar 20, 2019 Sale $22.25 417,000 9,278,250 2,732,730 Mar 25, 2019, 06:04 AM
5AM Ventures IV, L.P. 10% Owner Mar 18, 2019 Sale $24.25 154,839 3,754,954 2,507,797 Mar 20, 2019, 04:48 PM
5AM Ventures IV, L.P. 10% Owner Jan 22, 2019 Sale $21.88 262,153 5,734,597 3,107,642 Jan 24, 2019, 07:01 PM
PERCEPTIVE ADVISORS LLC Director Jul 18, 2018 Buy $21.30 307,648 6,552,902 307,648 Aug 27, 2018, 06:12 PM
PERCEPTIVE ADVISORS LLC Director Jul 20, 2018 Buy $17.00 400,000 6,800,000 2,587,953 Aug 27, 2018, 06:12 PM
5AM Ventures IV, L.P. 10% Owner Jul 20, 2018 Buy $17.00 115,000 1,955,000 3,359,309 Jul 20, 2018, 07:02 PM
PERCEPTIVE ADVISORS LLC Director Jul 20, 2018 Buy $17.00 400,000 6,800,000 2,280,305 Jul 20, 2018, 05:19 PM
Vivo Capital VIII, LLC 10% Owner Jul 20, 2018 Buy $18.62 353,180 6,575,421 3,025,339 Jul 20, 2018, 04:50 PM
Krasner Alan Seth Chief Medical Officer Jul 20, 2018 Buy $17.00 2,000 34,000 2,000 Jul 20, 2018, 04:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Betz Stephen F. Chief Scientific Officer 05/02/2022 65,252
Betz Stephen F. Chief Scientific Officer 04/18/2022 146,188
PERCEPTIVE ADVISORS LLC 10% Owner 04/18/2022 3,499,983
Struthers Richard Scott President & CEO 04/13/2022 3,719,625
Struthers Richard Scott President & CEO 04/05/2022 541,225
Betz Stephen F. Chief Scientific Officer 04/04/2022 215,761
Betz Stephen F. Chief Scientific Officer 04/01/2022 90,775
Betz Stephen F. Chief Scientific Officer 03/31/2022 87,700
Betz Stephen F. Chief Scientific Officer 03/15/2022 59,150
Madan Ajay Chief Development Officer 03/01/2022 178,920
Betz Stephen F. Chief Scientific Officer 03/01/2022 61,617
Betz Stephen F. Chief Scientific Officer 02/15/2022 58,213
Madan Ajay Chief Development Officer 02/07/2022 239,085
Betz Stephen F. Chief Scientific Officer 02/01/2022 58,681
Krasner Alan Seth Chief Medical Officer 01/19/2022 80,467
Krasner Alan Seth Chief Medical Officer 01/19/2022 142,080
Betz Stephen F. Chief Scientific Officer 01/18/2022 97,073
Betz Stephen F. Chief Scientific Officer 01/03/2022 200,847
Betz Stephen F. Chief Scientific Officer 12/28/2021 83,852
Betz Stephen F. Chief Scientific Officer 12/15/2021 136,826
Betz Stephen F. Chief Scientific Officer 12/01/2021 155,190
Betz Stephen F. Chief Scientific Officer 11/15/2021 151,619
Betz Stephen F. Chief Scientific Officer 11/16/2021 41,955
Betz Stephen F. Chief Scientific Officer 11/08/2021 110,846
Betz Stephen F. Chief Scientific Officer 11/05/2021 352,195
Betz Stephen F. Chief Scientific Officer 11/01/2021 140,510
Fust Matthew K Director 11/01/2021 17,102
Fust Matthew K Director 11/01/2021 228,327
Madan Ajay Chief Development Officer 10/28/2021 77,660
Betz Stephen F. Chief Scientific Officer 10/27/2021 71,991
Betz Stephen F. Chief Scientific Officer 10/21/2021 21,984
PERCEPTIVE ADVISORS LLC 10% Owner 10/25/2021 23,759,999
Fust Matthew K Director 09/08/2021 11,548
Fust Matthew K Director 09/08/2021 154,173
Struthers Richard Scott President & CEO 09/07/2021 250,000
Struthers Richard Scott President & CEO 09/07/2021 250,000
Struthers Richard Scott President & CEO 09/07/2021 250,000
Fust Matthew K Director 07/26/2021 9,550
Fust Matthew K Director 07/26/2021 97,950
Fust Matthew K Director 07/19/2021 9,550
Fust Matthew K Director 07/19/2021 97,500
Fust Matthew K Director 07/12/2021 9,550
Fust Matthew K Director 07/12/2021 103,550
PERCEPTIVE ADVISORS LLC 10% Owner 04/08/2021 4,999,996
Struthers Richard Scott President & CEO 12/03/2020 52,400
Struthers Richard Scott President & CEO 12/02/2020 12,600
Struthers Richard Scott President & CEO 07/16/2020 253,108
Struthers Richard Scott President & CEO 07/15/2020 267,722
WIERENGA WENDALL Director 04/28/2020 18,490
PERCEPTIVE ADVISORS LLC 10% Owner 04/17/2020 14,999,992
Vivo Capital VIII, LLC 10% Owner 04/17/2020 1,302,809
Vivo Capital VIII, LLC 10% Owner 04/16/2020 458,888
Vivo Capital VIII, LLC 10% Owner 04/15/2020 3,345,055
Vivo Capital VIII, LLC 10% Owner 04/03/2020 4,140,000
Vivo Capital VIII, LLC 10% Owner 04/07/2020 86,833
Vivo Capital VIII, LLC 10% Owner 03/09/2020 10,296
Vivo Capital VIII, LLC 10% Owner 02/10/2020 161,677
Vivo Capital VIII, LLC 10% Owner 02/07/2020 129,910
Vivo Capital VIII, LLC 10% Owner 02/04/2020 306,888
Vivo Capital VIII, LLC 10% Owner 01/30/2020 167,960
Vivo Capital VIII, LLC 10% Owner 01/29/2020 309,024
Vivo Capital VIII, LLC 10% Owner 01/31/2020 117,180
Fust Matthew K Director 12/16/2019 6,685
Fust Matthew K Director 12/16/2019 78,750
Struthers Richard Scott President & CEO 08/05/2019 19,100
5AM Ventures IV, L.P. Former 10% holder 06/21/2019 5,550,000
Vivo Capital VIII, LLC 10% Owner 03/20/2019 9,278,250
5AM Ventures IV, L.P. 10% Owner 03/18/2019 3,754,954
5AM Ventures IV, L.P. 10% Owner 01/22/2019 5,734,597
PERCEPTIVE ADVISORS LLC Director 07/18/2018 6,552,902
PERCEPTIVE ADVISORS LLC Director 07/20/2018 6,800,000
5AM Ventures IV, L.P. 10% Owner 07/20/2018 1,955,000
PERCEPTIVE ADVISORS LLC Director 07/20/2018 6,800,000
Vivo Capital VIII, LLC 10% Owner 07/20/2018 6,575,421
Krasner Alan Seth Chief Medical Officer 07/20/2018 34,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
09/30/2021
6.33%
1Q
12/31/2021
06/30/2021
9.67%
2Q
12/31/2021
03/31/2021
16.43%
3Q
12/31/2021
09/30/2020
29.82%
5Q
12/31/2021
06/30/2020
37.53%
6Q
Load More

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
6.33%
1Q
06/30/2021
9.67%
2Q
03/31/2021
16.43%
3Q
09/30/2020
29.82%
5Q
06/30/2020
37.53%
6Q
Load More